395
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Validation of Stroke Risk Factors in Patients with Acute Ischemic Stroke, Transient Ischemic Attack, or Intracerebral Hemorrhage on Taiwan’s National Health Insurance Claims Data

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 327-335 | Published online: 17 Mar 2022

References

  • GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820. doi:10.1016/s1474-4422(21)00252-0.
  • Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: a Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–e467. doi:10.1161/str.0000000000000375
  • Gorelick PB. Stroke Prevention. Arch Neurol. 1995;52(4):347–355. doi:10.1001/archneur.1995.00540280029015
  • O’Donnell MJ, Rangarajan S, Xavier D, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–775. doi:10.1016/s0140-6736(16)30506-2
  • Otite FO, Liaw N, Khandelwal P, et al. Increasing prevalence of vascular risk factors in patients with stroke: a call to action. Neurology. 2017;89(19):1985–1994. doi:10.1212/wnl.0000000000004617
  • Hsieh CY, Wu DP, Sung SF. Trends in vascular risk factors, stroke performance measures, and outcomes in patients with first-ever ischemic stroke in Taiwan between 2000 and 2012. J Neurol Sci. 2017;378:80–84. doi:10.1016/j.jns.2017.05.002
  • Chang KW, Xian Y, Zhao X, et al. Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke. Int J Cardiol. 2020;321:88–94. doi:10.1016/j.ijcard.2020.08.011
  • Shim DH, Kim Y, Roh J, et al. Hospital Volume Threshold Associated with Higher Survival after Endovascular Recanalization Therapy for Acute Ischemic Stroke. J Stroke. 2020;22(1):141–149. doi:10.5853/jos.2019.00955
  • Yu AYX, Holodinsky JK, Zerna C, et al. Use and Utility of Administrative Health Data for Stroke Research and Surveillance. Stroke. 2016;47(7):1946–1952. doi:10.1161/strokeaha.116.012390
  • Hsieh CY, Su CC, Shao SC, et al. Taiwan’s National Health Insurance Research Database: past and future. Clin Epidemiology. 2019;11:349–358. doi:10.2147/clep.s196293
  • Sung SF, Hsieh CY, Hu YH. Two Decades of Research Using Taiwan’s National Health Insurance Claims Data: bibliometric and Text Mining Analysis on PubMed. J Med Internet Res. 2020;22(6):e18457. doi:10.2196/18457
  • Kokotailo RA, Hill MD. Coding of Stroke and Stroke Risk Factors Using International Classification of Diseases, Revisions 9 and 10. Stroke. 2005;36(8):1776–1781. doi:10.1161/01.str.0000174293.17959.a1
  • Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139. doi:10.1097/01.mlr.0000182534.19832.83
  • Tonelli M, Wiebe N, Fortin M, et al. Methods for identifying 30 chronic conditions: application to administrative data. BMC Med Inform Decis Mak. 2015;15(1):31. doi:10.1186/s12911-015-0155-5
  • Sung SF, Hsieh CY, Lin HJ, Chen YW, Yang YHK, Li CY. Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database. Int J Cardiol. 2016;215:277–282. doi:10.1016/j.ijcard.2016.04.069
  • Hsu M, Wang C, Huang L, Lin C, Lin F, Toh S. Effect of ICD-9-CM to ICD-10-CM coding system transition on identification of common conditions: an interrupted time series analysis. Pharmacoepidemiol Drug Saf. 2021;30(12):1653–1674. doi:10.1002/pds.5330
  • Hsieh F-I, Lien L-M, Chen S-T, et al. Get With The Guidelines-Stroke Performance Indicators: surveillance of Stroke Care in the Taiwan Stroke Registry. Circulation. 2010;122(11):1116–1123. doi:10.1161/circulationaha.110.936526
  • Cheng CL, Kao YHY, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236–242. doi:10.1002/pds.2087
  • Youngson E, Welsh RC, Kaul P, McAlister F, Quan H, Bakal J. Defining and validating comorbidities and procedures in ICD-10 health data in ST-elevation myocardial infarction patients. Medicine. 2016;95(32):e4554. doi:10.1097/md.0000000000004554
  • Oake J, Aref-Eshghi E, Godwin M, et al. Using Electronic Medical Record to Identify Patients With Dyslipidemia in Primary Care Settings: international Classification of Disease Code Matters From One Region to a National Database. Biomed Inform Insights. 2017;2017(9). doi:10.4137/bii.s40801
  • Chen TT, Oldenburg B, Hsueh YS. Chronic care model in the diabetes pay-for-performance program in Taiwan: benefits, challenges and future directions. World J Diabetes. 2021;12(5):578–589. doi:10.4239/wjd.v12.i5.578
  • Sung SF, Lai ECC, Wu DP, Hsieh CY. Previously undiagnosed risk factors and medication nonadherence are prevalent in young adults with first‐ever stroke. Pharmacoepidemiol Drug Saf. 2017;26(12):1458–1464. doi:10.1002/pds.4250
  • Hsu CY, Chen WJ, Chen HM, Tsai HY, Hsiao FY. Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors. J Clin Pharm Ther. 2021;46(2):415–423. doi:10.1111/jcpt.13299
  • Kapral MK, Hall R, Fang J, et al. Predictors of Hospitalization in Patients With Transient Ischemic Attack or Minor Ischemic Stroke. Can J Neurol Sci. 2016;43(4):523–528. doi:10.1017/cjn.2016.12
  • Butt JH, Fosbøl EL, Østergaard L, et al. Effect of COVID-19 on First-Time Acute Stroke and Transient Ischemic Attack Admission Rates and Prognosis in Denmark. Circulation. 2020;142(12):1227–1229. doi:10.1161/circulationaha.120.050173
  • Kim HM, Smith EG, Stano CM, et al. Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use. BMC Health Serv Res. 2012;12(1):18. doi:10.1186/1472-6963-12-18
  • Kazzi ESA, Lau B, Li T, Schneider EB, Makary MA, Hutfless S. Differences in the Prevalence of Obesity, Smoking and Alcohol in the United States Nationwide Inpatient Sample and the Behavioral Risk Factor Surveillance System. PLoS One. 2015;10(11):e0140165. doi:10.1371/journal.pone.0140165
  • Suissa K, Schneeweiss S, Lin KJ, Brill G, Kim SC, Patorno E. Validation of obesity‐related diagnosis codes in claims data. Diabetes Obes Metab. 2021;23(12):2623–2631. doi:10.1111/dom.14512